Significantly reduced the fatty liver index, serum GGT and AST values; diminished chronic systemic inflammatory state; and lowered IL-6 and TNF-α concentrations in NAFLD patients. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatotic liver disease.